New therapies for children with uncontrolled asthma such as anti-IgE therapy (omalizumab) are very expensive and thus in the UK most large paediatric respiratory centres have set up specific ‘problem, severe asthma’ clinics. The gene discussed is IGHE; the disease is asthma.